Abstract
Prader-Willi Syndrome (PWS) is a multisystemic genetic disease characterized by hypotonia, mental retardation, characteristic facial appearance, hyperphagia, and compulsive eating due to hypothalamic dysfunction. PWS is caused by loss of function of genes located in chromosome 15q11-q13, an area subject to genomic imprinting. Obesity is a major cause of increased morbidity and mortality among patients with PWS. The objective of this study was to analyze the therapeutic options available for the treatment of the obesity in PWS including pharmacological and surgical strategies.
Author supplied keywords
Cite
CITATION STYLE
De Carvalho, D. F., Cercato, C., Almeida, M. Q., Mancini, M. C., & Halpern, A. (2007). Therapeutical approach of obesity in Prader-Willi syndrome. Arquivos Brasileiros de Endocrinologia e Metabologia. Sociedade Brasileira de Endocrinologia e Metabologia. https://doi.org/10.1590/s0004-27302007000600004
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
